Neurocrine Bioscience buy Oppenheimer Holdings Inc.
Start price
02.05.24
/
50%
€133.55
Target price
02.05.25
€201.87
Performance (%)
-22.16%
Price
04.10.24
€103.95
Summary
This prediction is currently active. The price of Neurocrine Bioscience has decreased since the start of the prediction. Compared to the start price this results in a performance of -22.16%. This prediction currently runs until 02.05.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | 0.873% | 0.873% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $200.00 to $216.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€140.30
02.08.24
02.08.24
€200.69
02.08.25
02.08.25
-25.91%
04.10.24
04.10.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€134.95
24.04.24
24.04.24
€187.12
24.04.25
24.04.25
-22.97%
04.10.24
04.10.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€128.35
18.03.24
18.03.24
€183.92
18.03.25
18.03.25
-19.01%
04.10.24
04.10.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€94.60
02.08.23
02.08.23
€137.10
02.08.24
02.08.24
47.73%
03.08.24
03.08.24